| Jaclyn M Schumann, | |
|
2100 Glenwood Ave, Joliet, IL 60435-5487 | |
| (815) 725-2121 | |
| (815) 741-5518 |
| Full Name | Jaclyn M Schumann |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 6 Years |
| Location | 2100 Glenwood Ave, Joliet, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184121030 | NPI | - | NPPES |
| 016005923 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 135-001000 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dupage Medical Group Ltd | 5496667941 | 1209 |
| North Point Orthopedics Llc | 5597018523 | 14 |
News Archive
Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.
Many patients with metastatic breast cancer believe that the primary goal in survival with new treatment should be to prolong life by at least a year over the survival they might expect from using current best therapies, a researcher will tell the seventh European Breast Cancer Conference in Barcelona today. This finding contrasts with doctors' perception that an additional four to six months' survival is significant enough to consider a new treatment worthwhile.
Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.
Avivia Health announces Avivia Select, a new series of affordable Disease Management and Wellness programs specifically designed to help companies provide important new benefits to their employees. Avivia Health is the only national provider of Disease Management and Wellness Solutions based on 60 years of evidence-based care by parent organization Kaiser Permanente.
› Verified 9 days ago
| Provider Name | Dupage Medical Group Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.
Many patients with metastatic breast cancer believe that the primary goal in survival with new treatment should be to prolong life by at least a year over the survival they might expect from using current best therapies, a researcher will tell the seventh European Breast Cancer Conference in Barcelona today. This finding contrasts with doctors' perception that an additional four to six months' survival is significant enough to consider a new treatment worthwhile.
Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.
Avivia Health announces Avivia Select, a new series of affordable Disease Management and Wellness programs specifically designed to help companies provide important new benefits to their employees. Avivia Health is the only national provider of Disease Management and Wellness Solutions based on 60 years of evidence-based care by parent organization Kaiser Permanente.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jaclyn M Schumann, Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Jaclyn M Schumann, 2100 Glenwood Ave, Joliet, IL 60435-5487 Ph: (815) 725-2121 |
News Archive
Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.
Many patients with metastatic breast cancer believe that the primary goal in survival with new treatment should be to prolong life by at least a year over the survival they might expect from using current best therapies, a researcher will tell the seventh European Breast Cancer Conference in Barcelona today. This finding contrasts with doctors' perception that an additional four to six months' survival is significant enough to consider a new treatment worthwhile.
Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.
Avivia Health announces Avivia Select, a new series of affordable Disease Management and Wellness programs specifically designed to help companies provide important new benefits to their employees. Avivia Health is the only national provider of Disease Management and Wellness Solutions based on 60 years of evidence-based care by parent organization Kaiser Permanente.
› Verified 9 days ago
Dr. Andrew Vernon Wahl, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1960 Essington Rd, Suite 103, Joliet, IL 60435 Phone: 815-436-3555 | |
Southshore Foot And Ankle Surgery Podiatrist Medicare: Medicare Enrolled Practice Location: 1026 Essington Rd, Joliet, IL 60435 Phone: 714-244-0101 | |
Dr. Ada Vera Paolucci, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1960 Essington Rd, Suite 103, Joliet, IL 60435 Phone: 815-436-3555 Fax: 815-436-3578 | |
Dr. Joe Mathew George, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1445 Essington Rd., Joliet, IL 60435 Phone: 815-741-6900 Fax: 815-741-6907 | |
Dr. An D Le, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1026 Essington Rd, Joliet, IL 60435 Phone: 714-244-0101 | |
Andrew Wahl And Ada Paolucci Podiatrist Medicare: Medicare Enrolled Practice Location: 1960 Essington Rd, Ste 103, Joliet, IL 60435 Phone: 815-436-3555 Fax: 815-436-3578 |